Laboratoires Euromedis Société anonyme

ENXTPA:ALEMG Stock Report

Market Cap: €12.3m

Laboratoires Euromedis Société anonyme Future Growth

Future criteria checks 1/6

Laboratoires Euromedis Société anonyme's earnings are forecast to decline at 90.1% per annum while its annual revenue is expected to grow at 8.3% per year. EPS is expected to grow by 1.8% per annum. Return on equity is forecast to be 5.6% in 3 years.

Key information

-90.1%

Earnings growth rate

1.8%

EPS growth rate

Medical Equipment earnings growth14.9%
Revenue growth rate8.3%
Future return on equity5.6%
Analyst coverage

Low

Last updated06 Jan 2025

Recent future growth updates

Recent updates

Does Laboratoires Euromedis Société anonyme (EPA:ALEMG) Have A Healthy Balance Sheet?

Nov 19
Does Laboratoires Euromedis Société anonyme (EPA:ALEMG) Have A Healthy Balance Sheet?

Little Excitement Around Laboratoires Euromedis Société anonyme's (EPA:ALEMG) Revenues

Aug 14
Little Excitement Around Laboratoires Euromedis Société anonyme's (EPA:ALEMG) Revenues

Health Check: How Prudently Does Euromedis Groupe (EPA:ALEMG) Use Debt?

Dec 12
Health Check: How Prudently Does Euromedis Groupe (EPA:ALEMG) Use Debt?

Investors Aren't Entirely Convinced By Euromedis Groupe's (EPA:ALEMG) Revenues

Jul 29
Investors Aren't Entirely Convinced By Euromedis Groupe's (EPA:ALEMG) Revenues

Health Check: How Prudently Does Euromedis Groupe (EPA:ALEMG) Use Debt?

Oct 05
Health Check: How Prudently Does Euromedis Groupe (EPA:ALEMG) Use Debt?

Euromedis Groupe (EPA:ALEMG) Might Have The Makings Of A Multi-Bagger

Jun 14
Euromedis Groupe (EPA:ALEMG) Might Have The Makings Of A Multi-Bagger

Under The Bonnet, Euromedis Groupe's (EPA:ALEMG) Returns Look Impressive

Oct 03
Under The Bonnet, Euromedis Groupe's (EPA:ALEMG) Returns Look Impressive

Euromedis Groupe's (EPA:ALEMG) Earnings Are Of Questionable Quality

Jun 12
Euromedis Groupe's (EPA:ALEMG) Earnings Are Of Questionable Quality

Has Euromedis Groupe (EPA:ALEMG) Got What It Takes To Become A Multi-Bagger?

Mar 18
Has Euromedis Groupe (EPA:ALEMG) Got What It Takes To Become A Multi-Bagger?

The Euromedis Groupe (EPA:ALEMG) Share Price Has Gained 173%, So Why Not Pay It Some Attention?

Feb 11
The Euromedis Groupe (EPA:ALEMG) Share Price Has Gained 173%, So Why Not Pay It Some Attention?

Euromedis Groupe's (EPA:ALEMG) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Jan 14
Euromedis Groupe's (EPA:ALEMG) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Is Euromedis Groupe (EPA:ALEMG) A Risky Investment?

Dec 19
Is Euromedis Groupe (EPA:ALEMG) A Risky Investment?

Calculating The Fair Value Of Euromedis Groupe (EPA:ALEMG)

Nov 22
Calculating The Fair Value Of Euromedis Groupe (EPA:ALEMG)

Earnings and Revenue Growth Forecasts

ENXTPA:ALEMG - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263921N/A1
12/31/20253811N/A1
12/31/20243616N/A1
6/30/20243118N/AN/AN/A
3/31/20243416N/AN/AN/A
12/31/20233713N/AN/AN/A
9/30/2023434N/AN/AN/A
6/30/202350-6-5-3N/A
3/31/202352-6-4-2N/A
12/31/202254-6-2-1N/A
9/30/202262-768N/A
6/30/202269-81517N/A
3/31/202291-31618N/A
12/31/202111221719N/A
9/30/20211581389N/A
6/30/202120423-2-1N/A
3/31/20211992366N/A
12/31/2020193231314N/A
9/30/2020147121314N/A
6/30/202010001314N/A
3/31/202089-257N/A
12/31/201977-4-2-1N/A
12/31/201876-5-3-2N/A
1/31/201876-1N/A1N/A
10/31/201775-1N/A1N/A
7/31/2017740N/A1N/A
4/30/2017741N/A1N/A
1/31/2017741N/A0N/A
10/31/2016741N/A1N/A
7/31/2016741N/A1N/A
4/30/2016732N/A3N/A
1/31/2016722N/A5N/A
10/31/2015722N/A4N/A
7/31/2015722N/A3N/A
4/30/2015712N/A2N/A
1/31/2015712N/A1N/A
10/31/2014722N/A2N/A
7/31/2014723N/A3N/A
4/30/2014743N/A3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ALEMG's earnings are forecast to decline over the next 3 years (-90.1% per year).

Earnings vs Market: ALEMG's earnings are forecast to decline over the next 3 years (-90.1% per year).

High Growth Earnings: ALEMG's earnings are forecast to decline over the next 3 years.

Revenue vs Market: ALEMG's revenue (8.3% per year) is forecast to grow faster than the French market (5.4% per year).

High Growth Revenue: ALEMG's revenue (8.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ALEMG's Return on Equity is forecast to be low in 3 years time (5.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 18:55
End of Day Share Price 2025/01/31 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Laboratoires Euromedis Société anonyme is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stephanie LefebvreGilbert Dupont
Sandrine CauvinGilbert Dupont
Romain FreismuthPortzamparc BNP Paribas